Kenneth Edward
De novo malignancies following kidney transplantation pose a growing concern in clinical practice. While advancements in immunosuppressive regimens have improved graft survival, they also heighten the risk of malignancy development. This review summarizes the epidemiology, risk factors, pathogenesis and management strategies for de novo malignancies post kidney transplantation. Understanding these factors is crucial for optimizing long-term outcomes in transplant recipients.
English 
Spanish 
Chinese 
Russian 
German 
Japanese 
Portuguese 
Hindi